Arca
Skip to content

Access hsTnI

Immunoassay Method, Troponin Subunit. 510(k) K230648, from Beckman Coulter, Inc. (Chaska, MN). Product code MMI, class 2.

As of Nov 17, 2026, K230648 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Dec 4, 2023 after 270 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Dec 4, 2023
  • Review time: 270 days
  • Recalls: 1
  • Cited as a predicate by: 2 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Access hsTnI is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of cardiac troponin I (cTnI) levels in human serum and plasma using the Access 2 Immunoassay Systems to aid in the diagnosis of myocardial infarction (MI).

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • Access hsTnlK172787 · Beckman Coulter, Inc. · Jun 14, 2018

Cited as a Predicate

2 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K230648, newest first; each opens FDA's recall record
StartedReasonStatus
Nov 18, 2024Z-0727-2025Beckman Coulter, Inc. is recalling their Access hsTnI assay, a medical device by correction. The reason for the recall is: high troponin antigen (>55,000 pg/mL) can contaminate an analyzers probe and cause inter-assay…Open, Classified

Other MMI Clearances

The newest 510(k)s for the same product code; their median review was 266 days; see every MMI device

Record

Type
Traditional
Received
Mar 9, 2023
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1215

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.